Enterprise Value
93.95M
Cash
46.52M
Avg Qtr Burn
-5.073M
Short % of Float
0.75%
Insider Ownership
26.47%
Institutional Own.
29.29%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DM199 (KLK1 protein) Details Heart disease, Ischemic stroke | Phase 2/3 Data readout | |
DM199 (KLK1 protein) Details Chronic inflammatory disorder, Inflammatory disease, Kidney disease, IgA nephropathy, Chronic kidney disease | Phase 2 Data readout | |
DM199 (KLK1 protein) Details Preeclampsia | Phase 2 Initiation |